Droeser, R. A. and Hirt, C. and Viehl, C. T. and Frey, D. M. and Nebiker, C. and Huber, X. and Zlobec, I. and Eppenberger-Castori, S. and Tzankov, A. and Rosso, R. and Zuber, M. and Muraro, M. G. and Amicarella, F. and Cremonesi, E. and Heberer, M. and Iezzi, G. and Lugli, A. and Terracciano, L. and Sconocchia, G. and Oertli, D. and Spagnoli, G. C. and Tornillo, L.. (2013) Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. European journal of cancer, Vol. 49, H. 9. pp. 2233-2242.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6338101
Downloads: Statistics Overview
Abstract
BACKGROUND: Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and associated with poor prognosis. Therapeutic antibodies inhibiting PD-1/PD-L1 interaction have been developed. MATERIALS AND METHODS: A tissue microarray (n=1491) including healthy colon mucosa and clinically annotated colorectal cancer (CRC) specimens was stained with two PD-L1 specific antibody preparations. Surgically excised CRC specimens were enzymatically digested and analysed for cluster of differentiation 8 (CD8) and PD-1 expression. RESULTS: Strong PD-L1 expression was observed in 37% of mismatch repair (MMR)-proficient and in 29% of MMR-deficient CRC. In MMR-proficient CRC strong PD-L1 expression correlated with infiltration by CD8+ lymphocytes (P=0.0001) which did not express PD-1. In univariate analysis, strong PD-L1 expression in MMR-proficient CRC was significantly associated with early T stage, absence of lymph node metastases, lower tumour grade, absence of vascular invasion and significantly improved survival in training (P=0.0001) and validation (P=0.03) sets. A similar trend (P=0.052) was also detectable in multivariate analysis including age, sex, T stage, N stage, tumour grade, vascular invasion, invasive margin and MMR status. Interestingly, programmed death receptor ligand 1 (PDL-1) and interferon (IFN)-gamma gene expression, as detected by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in fresh frozen CRC specimens (n=42) were found to be significantly associated (r=0.33, P=0.03). CONCLUSION: PD-L1 expression is paradoxically associated with improved survival in MMR-proficient CRC.
Faculties and Departments: | 03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Oncology Surgery (Spagnoli) 03 Faculty of Medicine > Bereich Operative Fächer (Klinik) > Ehemalige Einheiten Operative Fächer (Klinik) > Chirurgische Forschung (Heberer) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Operative Fächer (Klinik) > Ehemalige Einheiten Operative Fächer (Klinik) > Chirurgische Forschung (Heberer) 03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Cancer Immunotherapy (Iezzi) |
---|---|
UniBasel Contributors: | Spagnoli, Giulio C. and Heberer, Michael and Iezzi, Giandomenica |
Item Type: | Article, refereed |
Article Subtype: | Research Article |
Publisher: | Pergamon Press |
ISSN: | 0959-8049 |
Note: | Publication type according to Uni Basel Research Database: Journal article |
Related URLs: | |
Identification Number: |
|
Last Modified: | 06 Mar 2015 07:44 |
Deposited On: | 06 Mar 2015 07:44 |
Repository Staff Only: item control page